about
Laryngeal involvement in juvenile idiopathic arthritis patients.Pleiotrophin, the angiogenic and mitogenic growth factor: levels in serum and synovial fluid in rheumatoid arthritis and osteoarthritis : And correlation with clinical, laboratory and radiological indices.Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus.Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease.Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement.Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.Axial involvement with facet joint arthropathy and bony ankylosis in a case of camptodactyly, arthropathy, coxa vara, pericarditis (CACP) syndrome.Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity.Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.Relationship between nailfold capillary abnormalities and vestibular dysfunction in systemic sclerosis.Correlation of myomir-206 and proinflammatory cytokines (IL-16 and IL-17) in patients with rheumatoid arthritisCD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroidsIL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestationsClinical significance of CCN2/connective tissue growth factor in Behçet's disease patients
P50
Q38854208-40B7D8C0-2E57-4E06-B352-BFF95EF36301Q39140572-3CCFDA57-FFBC-4E6B-9FD7-9FC4D26229BEQ39506842-D12BD910-05E9-476C-AF58-F4C9A74D2DC0Q39506874-C65EC8DD-870B-4FA7-8F27-A19C15F5A6CEQ40001918-B1283818-FEC7-4CAE-906C-4CCD6A7B3191Q41486353-6168430B-766B-4530-BF6D-3E360E2A0304Q42206002-EC989EE7-CD5D-4397-B271-34825B870B28Q44423085-9B550805-76D1-4CAB-9D26-00C5C8724292Q46290723-1657CA29-2109-453D-BA59-1B289F8829E7Q46346251-5805C8AD-EB45-4233-ADC3-FCE3ACEDAB05Q46400711-9659226E-F178-4179-AF96-51C96D91D1A6Q46511708-3EDAA13D-CC26-4909-B313-1ACE53E493BFQ46605188-A7ADE4FE-E95F-4784-A274-52A9FE1B0B5FQ46666806-F7D5B8E9-B75C-4D6A-8151-3E30D3195829Q51541656-A2CF0EDD-3C47-4666-BF2B-F5A9FED53028Q64082718-F83F7498-E433-4CEF-9409-0172F843E955Q80770836-D90486CE-14F5-45CF-90C4-2231B8EC4D36Q92253143-9CFB417C-1628-47BB-B7A9-EC504AD2AFD5Q92262800-45FF49C1-D900-4078-98BF-078A9914DE1A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Iman H. Bassyouni
@ast
Iman H. Bassyouni
@en
Iman H. Bassyouni
@es
Iman H. Bassyouni
@nl
Iman H. Bassyouni
@sl
type
label
Iman H. Bassyouni
@ast
Iman H. Bassyouni
@en
Iman H. Bassyouni
@es
Iman H. Bassyouni
@nl
Iman H. Bassyouni
@sl
prefLabel
Iman H. Bassyouni
@ast
Iman H. Bassyouni
@en
Iman H. Bassyouni
@es
Iman H. Bassyouni
@nl
Iman H. Bassyouni
@sl
P106
P1153
16033074000
P31
P496
0000-0003-3283-7297